{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:44:21Z","timestamp":1790847861006,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007279","name":"Shanghai Municipal Health Bureau","doi-asserted-by":"publisher","award":["shslczdzk03402"],"award-info":[{"award-number":["shslczdzk03402"]}],"id":[{"id":"10.13039\/501100007279","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00259-025-07111-7","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T08:12:30Z","timestamp":1738311150000},"page":"2258-2266","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Head-to-Head comparison of [18F]FDG, [18F]FMZ, and [18F]SynVesT-1 positron emission tomography imaging in patients with drug-resistant epilepsy"],"prefix":"10.1007","volume":"52","author":[{"given":"Guanglei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengping","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqi","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shize","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanjuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihui","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2667-281X","authenticated-orcid":false,"given":"Fang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,31]]},"reference":[{"key":"7111_CR1","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/s0140-6736(18)32596-0","volume":"393","author":"RD Thijs","year":"2019","unstructured":"Thijs RD, Surges R, O\u2019Brien TJ, Sander JW. Epilepsy in adults. Lancet. 2019;393:689\u2013701. https:\/\/doi.org\/10.1016\/s0140-6736(18)32596-0.","journal-title":"Lancet"},{"issue":"Suppl 1","key":"7111_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1528-1167.2007.00992.x","volume":"48","author":"JA French","year":"2007","unstructured":"French JA. Refractory epilepsy: clinical overview. Epilepsia. 2007;48(Suppl 1):3\u20137. https:\/\/doi.org\/10.1111\/j.1528-1167.2007.00992.x.","journal-title":"Epilepsia"},{"key":"7111_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2174\/1570159x15666170504123316","volume":"16","author":"J Sheng","year":"2018","unstructured":"Sheng J, Liu S, Qin H, Li B, Zhang X. Drug-Resistant Epilepsy and surgery. Curr Neuropharmacol. 2018;16:17\u201328. https:\/\/doi.org\/10.2174\/1570159x15666170504123316.","journal-title":"Curr Neuropharmacol"},{"key":"7111_CR4","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.3171\/2018.7.Focus18220","volume":"45","author":"J Pindrik","year":"2018","unstructured":"Pindrik J, Hoang N, Smith L, Halverson M, Wojnaroski M, McNally K, et al. Preoperative evaluation and surgical management of infants and toddlers with drug-resistant epilepsy. Neurosurg Focus. 2018;45:E3. https:\/\/doi.org\/10.3171\/2018.7.Focus18220.","journal-title":"Neurosurg Focus"},{"key":"7111_CR5","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/epi.17853","volume":"65","author":"D Hansen","year":"2024","unstructured":"Hansen D, Shandley S, Olaya J, Hauptman J, Auguste K, Ostendorf AP, et al. A multi-center comparison of surgical techniques for corpus callosotomy in pediatric drug-resistant epilepsy. Epilepsia. 2024;65:422\u20139. https:\/\/doi.org\/10.1111\/epi.17853.","journal-title":"Epilepsia"},{"key":"7111_CR6","doi-asserted-by":"publisher","first-page":"E73","DOI":"10.1093\/neuros\/nyaa307","volume":"88","author":"I Pan","year":"2020","unstructured":"Pan I, LoPresti MA, Clarke DF, Lam S. The effectiveness of Medical and Surgical Treatment for Children with Refractory Epilepsy. Neurosurgery. 2020;88:E73\u201382. https:\/\/doi.org\/10.1093\/neuros\/nyaa307.","journal-title":"Neurosurgery"},{"key":"7111_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3171\/2022.4.Jns212753","volume":"138","author":"M Kunz","year":"2023","unstructured":"Kunz M, Karschnia P, Borggraefe I, Noachtar S, Tonn JC, Vollmar C. Seizure-free outcome and safety of repeated epilepsy surgery for persistent or recurrent seizures. J Neurosurg. 2023;138:9\u201318. https:\/\/doi.org\/10.3171\/2022.4.Jns212753.","journal-title":"J Neurosurg"},{"key":"7111_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00259-020-04935-3","volume":"48","author":"F Liu","year":"2021","unstructured":"Liu F, Ruan W, Deng X, Song Y, Song W, Hu F, et al. Efficacy of delayed (18)F-FDG hybrid PET\/MRI for epileptic focus identification: a prospective cohort study. Eur J Nucl Med Mol Imaging. 2021;48:293\u2013301. https:\/\/doi.org\/10.1007\/s00259-020-04935-3.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7111_CR9","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.2967\/jnumed.110.075390","volume":"51","author":"A Kumar","year":"2010","unstructured":"Kumar A, Juh\u00e1sz C, Asano E, Sood S, Muzik O, Chugani HT. Objective detection of epileptic foci by 18F-FDG PET in children undergoing epilepsy surgery. J Nucl Med. 2010;51:1901\u20137. https:\/\/doi.org\/10.2967\/jnumed.110.075390.","journal-title":"J Nucl Med"},{"key":"7111_CR10","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1002\/ana.410320613","volume":"32","author":"WH Theodore","year":"1992","unstructured":"Theodore WH, Sato S, Kufta C, Balish MB, Bromfield EB, Leiderman DB. Temporal lobectomy for uncontrolled seizures: the role of positron emission tomography. Ann Neurol. 1992;32:789\u201394. https:\/\/doi.org\/10.1002\/ana.410320613.","journal-title":"Ann Neurol"},{"key":"7111_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/ana.21389","volume":"64","author":"RC Knowlton","year":"2008","unstructured":"Knowlton RC, Elgavish RA, Limdi N, Bartolucci A, Ojha B, Blount J, et al. Functional imaging: I. relative predictive value of intracranial electroencephalography. Ann Neurol. 2008;64:25\u201334. https:\/\/doi.org\/10.1002\/ana.21389.","journal-title":"Ann Neurol"},{"key":"7111_CR12","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1111\/epi.17194","volume":"63","author":"M Steinbrenner","year":"2022","unstructured":"Steinbrenner M, Duncan JS, Dickson J, Rathore C, W\u00e4chter B, Aygun N, et al. Utility of 18F-fluorodeoxyglucose positron emission tomography in presurgical evaluation of patients with epilepsy: a multicenter study. Epilepsia. 2022;63:1238\u201352. https:\/\/doi.org\/10.1111\/epi.17194.","journal-title":"Epilepsia"},{"key":"7111_CR13","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1212\/WNL.0b013e31820203a9","volume":"75","author":"F Chassoux","year":"2010","unstructured":"Chassoux F, Rodrigo S, Semah F, Beuvon F, Landre E, Devaux B, et al. FDG-PET improves surgical outcome in negative MRI Taylor-type focal cortical dysplasias. Neurology. 2010;75:2168\u201375. https:\/\/doi.org\/10.1212\/WNL.0b013e31820203a9.","journal-title":"Neurology"},{"key":"7111_CR14","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1007\/s00259-020-04791-1","volume":"47","author":"S Lagarde","year":"2020","unstructured":"Lagarde S, Boucekine M, McGonigal A, Carron R, Scavarda D, Trebuchon A, et al. Relationship between PET metabolism and SEEG epileptogenicity in focal lesional epilepsy. Eur J Nucl Med Mol Imaging. 2020;47:3130\u201342. https:\/\/doi.org\/10.1007\/s00259-020-04791-1.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7111_CR15","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1093\/brain\/awl232","volume":"130","author":"AB Vinton","year":"2007","unstructured":"Vinton AB, Carne R, Hicks RJ, Desmond PM, Kilpatrick C, Kaye AH, et al. The extent of resection of FDG-PET hypometabolism relates to outcome of temporal lobectomy. Brain. 2007;130:548\u201360. https:\/\/doi.org\/10.1093\/brain\/awl232.","journal-title":"Brain"},{"key":"7111_CR16","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1038\/511s4a","volume":"511","author":"M Eisenstein","year":"2014","unstructured":"Eisenstein M, Neurobiology. Unrestrained excitement. Nature. 2014;511:S4\u20136. https:\/\/doi.org\/10.1038\/511s4a.","journal-title":"Nature"},{"key":"7111_CR17","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.2967\/jnumed.112.107359","volume":"54","author":"L Vivash","year":"2013","unstructured":"Vivash L, Gregoire MC, Lau EW, Ware RE, Binns D, Roselt P, et al. 18F-flumazenil: a \u03b3-aminobutyric acid A-specific PET radiotracer for the localization of drug-resistant temporal lobe epilepsy. J Nucl Med. 2013;54:1270\u20137. https:\/\/doi.org\/10.2967\/jnumed.112.107359.","journal-title":"J Nucl Med"},{"key":"7111_CR18","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1001\/jamaneurol.2018.1836","volume":"75","author":"MK Chen","year":"2018","unstructured":"Chen MK, Mecca AP, Naganawa M, Finnema SJ, Toyonaga T, Lin SF, et al. Assessing synaptic density in Alzheimer Disease with synaptic vesicle glycoprotein 2A Positron Emission Tomographic Imaging. JAMA Neurol. 2018;75:1215\u201324. https:\/\/doi.org\/10.1001\/jamaneurol.2018.1836.","journal-title":"JAMA Neurol"},{"key":"7111_CR19","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1111\/epi.16653","volume":"61","author":"SJ Finnema","year":"2020","unstructured":"Finnema SJ, Toyonaga T, Detyniecki K, Chen MK, Dias M, Wang Q, et al. Reduced synaptic vesicle protein 2A binding in temporal lobe epilepsy: a [(11) C]UCB-J positron emission tomography study. Epilepsia. 2020;61:2183\u201393. https:\/\/doi.org\/10.1111\/epi.16653.","journal-title":"Epilepsia"},{"key":"7111_CR20","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1007\/s00259-021-05665-w","volume":"49","author":"Y Tang","year":"2022","unstructured":"Tang Y, Yu J, Zhou M, Li J, Long T, Li Y, et al. Cortical abnormalities of synaptic vesicle protein 2A in focal cortical dysplasia type II identified in vivo with (18)F-SynVesT-1 positron emission tomography imaging. Eur J Nucl Med Mol Imaging. 2022;49:3482\u201391. https:\/\/doi.org\/10.1007\/s00259-021-05665-w.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7111_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neuroscience.2021.10.012","volume":"478","author":"S Ren","year":"2021","unstructured":"Ren S, Huang Q, Bao W, Jiang D, Xiao J, Li J, et al. Metabolic Brain Network and Surgical outcome in temporal lobe Epilepsy: a Graph Theoretical Study based on (18)F-fluorodeoxyglucose PET. Neuroscience. 2021;478:39\u201348. https:\/\/doi.org\/10.1016\/j.neuroscience.2021.10.012.","journal-title":"Neuroscience"},{"key":"7111_CR22","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1177\/0271678x231153730","volume":"43","author":"J Zhang","year":"2023","unstructured":"Zhang J, Wang J, Xu X, You Z, Huang Q, Huang Y, et al. In vivo synaptic density loss correlates with impaired functional and related structural connectivity in Alzheimer\u2019s disease. J Cereb Blood Flow Metab. 2023;43:977\u201388. https:\/\/doi.org\/10.1177\/0271678x231153730.","journal-title":"J Cereb Blood Flow Metab"},{"key":"7111_CR23","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.yebeh.2011.06.022","volume":"22","author":"AF Struck","year":"2011","unstructured":"Struck AF, Hall LT, Floberg JM, Perlman SB, Dulli DA. Surgical decision making in temporal lobe epilepsy: a comparison of [(18)F]FDG-PET, MRI, and EEG. Epilepsy Behav. 2011;22:293\u20137. https:\/\/doi.org\/10.1016\/j.yebeh.2011.06.022.","journal-title":"Epilepsy Behav"},{"key":"7111_CR24","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.eplepsyres.2014.06.012","volume":"108","author":"C Rathore","year":"2014","unstructured":"Rathore C, Dickson JC, Teot\u00f3nio R, Ell P, Duncan JS. The utility of 18F-fluorodeoxyglucose PET (FDG PET) in epilepsy surgery. Epilepsy Res. 2014;108:1306\u201314. https:\/\/doi.org\/10.1016\/j.eplepsyres.2014.06.012.","journal-title":"Epilepsy Res"},{"key":"7111_CR25","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3389\/fneur.2017.00453","volume":"8","author":"VC Mendes Coelho","year":"2017","unstructured":"Mendes Coelho VC, Morita ME, Amorim BJ, Ramos CD, Yasuda CL, Tedeschi H, et al. Automated online quantification method for (18)F-FDG Positron Emission Tomography\/CT Improves Detection of the Epileptogenic Zone in patients with Pharmacoresistant Epilepsy. Front Neurol. 2017;8:453. https:\/\/doi.org\/10.3389\/fneur.2017.00453.","journal-title":"Front Neurol"},{"issue":"Pt 11","key":"7111_CR26","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1093\/brain\/121.11.2067","volume":"121","author":"P Ryvlin","year":"1998","unstructured":"Ryvlin P, Bouvard S, Le Bars D, De Lam\u00e9rie G, Gr\u00e9goire MC, Kahane P, et al. Clinical utility of flumazenil-PET versus [18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients. Brain. 1998;121(Pt 11):2067\u201381. https:\/\/doi.org\/10.1093\/brain\/121.11.2067.","journal-title":"Brain"},{"key":"7111_CR27","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1111\/ejn.12360","volume":"38","author":"JG Mendoza-Torreblanca","year":"2013","unstructured":"Mendoza-Torreblanca JG, Vanoye-Carlo A, Phillips-Farf\u00e1n BV, Carmona-Aparicio L, G\u00f3mez-Lira G. Synaptic vesicle protein 2A: basic facts and role in synaptic function. Eur J Neurosci. 2013;38:3529\u201339. https:\/\/doi.org\/10.1111\/ejn.12360.","journal-title":"Eur J Neurosci"},{"key":"7111_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neuroscience.2012.06.058","volume":"221","author":"R Hanaya","year":"2012","unstructured":"Hanaya R, Hosoyama H, Sugata S, Tokudome M, Hirano H, Tokimura H, et al. Low distribution of synaptic vesicle protein 2A and synaptotagimin-1 in the cerebral cortex and hippocampus of spontaneously epileptic rats exhibiting both tonic convulsion and absence seizure. Neuroscience. 2012;221:12\u201320. https:\/\/doi.org\/10.1016\/j.neuroscience.2012.06.058.","journal-title":"Neuroscience"},{"key":"7111_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-024-06593-1","author":"L Xiao","year":"2024","unstructured":"Xiao L, Yang J, Zhu H, Zhou M, Li J, Liu D, et al. [(18)F]SynVesT-1 and [(18)F]FDG quantitative PET imaging in the presurgical evaluation of MRI-negative children with focal cortical dysplasia type II. Eur J Nucl Med Mol Imaging. 2024. https:\/\/doi.org\/10.1007\/s00259-024-06593-1.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7111_CR30","doi-asserted-by":"publisher","first-page":"15268","DOI":"10.1073\/pnas.96.26.15268","volume":"96","author":"KM Crowder","year":"1999","unstructured":"Crowder KM, Gunther JM, Jones TA, Hale BD, Zhang HZ, Peterson MR, et al. Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A). Proc Natl Acad Sci U S A. 1999;96:15268\u201373. https:\/\/doi.org\/10.1073\/pnas.96.26.15268.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7111_CR31","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1212\/wnl.45.5.934","volume":"45","author":"DE Burdette","year":"1995","unstructured":"Burdette DE, Sakurai SY, Henry TR, Ross DA, Pennell PB, Frey KA, et al. Temporal lobe central benzodiazepine binding in unilateral mesial temporal lobe epilepsy. Neurology. 1995;45:934\u201341. https:\/\/doi.org\/10.1212\/wnl.45.5.934.","journal-title":"Neurology"},{"issue":"Pt 5","key":"7111_CR32","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1093\/brain\/119.5.1677","volume":"119","author":"MJ Koepp","year":"1996","unstructured":"Koepp MJ, Richardson MP, Brooks DJ, Poline JB, Van Paesschen W, Friston KJ, et al. Cerebral benzodiazepine receptors in hippocampal sclerosis. An objective in vivo analysis. Brain. 1996;119(Pt 5):1677\u201387. https:\/\/doi.org\/10.1093\/brain\/119.5.1677.","journal-title":"Brain"},{"key":"7111_CR33","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1136\/jnnp.62.2.141","volume":"62","author":"RM Debets","year":"1997","unstructured":"Debets RM, Sadzot B, van Isselt JW, Brekelmans GJ, Meiners LC, van Huffelen AO, et al. Is 11\u00a0C-flumazenil PET superior to 18FDG PET and 123I-iomazenil SPECT in presurgical evaluation of temporal lobe epilepsy? J Neurol Neurosurg Psychiatry. 1997;62:141\u201350. https:\/\/doi.org\/10.1136\/jnnp.62.2.141.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7111_CR34","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1093\/brain\/awn111","volume":"131","author":"F Bartolomei","year":"2008","unstructured":"Bartolomei F, Chauvel P, Wendling F. Epileptogenicity of brain structures in human temporal lobe epilepsy: a quantified study from intracerebral EEG. Brain. 2008;131:1818\u201330. https:\/\/doi.org\/10.1093\/brain\/awn111.","journal-title":"Brain"},{"key":"7111_CR35","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/j.1528-1167.2008.01727.x","volume":"50","author":"EA van Vliet","year":"2009","unstructured":"van Vliet EA, Aronica E, Redeker S, Boer K, Gorter JA. Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy. Epilepsia. 2009;50:422\u201333. https:\/\/doi.org\/10.1111\/j.1528-1167.2008.01727.x.","journal-title":"Epilepsia"},{"key":"7111_CR36","doi-asserted-by":"publisher","first-page":"9861","DOI":"10.1073\/pnas.0308208101","volume":"101","author":"BA Lynch","year":"2004","unstructured":"Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci U S A. 2004;101:9861\u20136. https:\/\/doi.org\/10.1073\/pnas.0308208101.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7111_CR37","doi-asserted-by":"publisher","unstructured":"Danish A, Namasivayam V, Schiedel AC, M\u00fcller CE. Interaction of approved drugs with synaptic vesicle protein 2A. Arch Pharm (Weinheim). 2017;350. https:\/\/doi.org\/10.1002\/ardp.201700003.","DOI":"10.1002\/ardp.201700003"},{"key":"7111_CR38","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/pcn.13682","volume":"78","author":"L Xiao","year":"2024","unstructured":"Xiao L, Xiang S, Chen C, Zhu H, Zhou M, Tang Y, et al. Association of synaptic density and cognitive performance in temporal lobe epilepsy: humans and animals PET imaging study with [(18)F]SynVesT-1. Psychiatry Clin Neurosci. 2024;78:456\u201367. https:\/\/doi.org\/10.1111\/pcn.13682.","journal-title":"Psychiatry Clin Neurosci"},{"key":"7111_CR39","doi-asserted-by":"publisher","first-page":"117877","DOI":"10.1016\/j.neuroimage.2021.117877","volume":"232","author":"L Michiels","year":"2021","unstructured":"Michiels L, Delva A, van Aalst J, Ceccarini J, Vandenberghe W, Vandenbulcke M, et al. Synaptic density in healthy human aging is not influenced by age or sex: a (11)C-UCB-J PET study. NeuroImage. 2021;232:117877. https:\/\/doi.org\/10.1016\/j.neuroimage.2021.117877.","journal-title":"NeuroImage"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07111-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07111-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07111-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T10:18:00Z","timestamp":1748427480000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07111-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["7111"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07111-7","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,31]]},"assertion":[{"value":"18 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval was obtained from the ethics committee of Huashan Hospital Institutional Review Board (HIRB), Fudan University, China. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants or legal guardians included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for participate"}},{"value":"Patients signed informed consent regarding the publication of their data and photographs.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}